New aspects in the pathogenesis of enteropathic hemolytic uremic syndrome

Seminars in Thrombosis and Hemostasis

Volumn 32, Issue 2, 2006, Pages 105-112

  Karch, Helge ^a   Friedrich, Alexander W ^a   Gerber, Angela ^b   Zimmerhackl, Lothar B ^c   Schmidt, M Alexander ^a   Bielaszewska, Martina ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

Children; Endothelial cells; Endothelial damage; Hemolytic uremic syndrome (HUS); Pathogenesis of HUS; Shiga toxin

Indexed keywords

ADHESIN; CYTOLETHAL DISTENDING TOXIN; MESSENGER RNA; SHIGA TOXIN; VIRULENCE FACTOR;

ARTICLE; BACTERIAL STRAIN; CHO CELL; DIARRHEA; ENDOTHELIUM CELL; ENTEROPATHY; ENZYME IMMUNOASSAY; ESCHERICHIA COLI O157; GENETIC TRANSCRIPTION; GENOTYPE; HEMOLYTIC UREMIC SYNDROME; HUMAN; LATEX AGGLUTINATION TEST; NONHUMAN; PATHOGENESIS; PATHOGENICITY; POLYMERASE CHAIN REACTION; PREDICTION; PRIORITY JOURNAL; SHIGA TOXIN PRODUCING ESCHERICHIA COLI;

EID: 33645567375     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-939766     Document Type: Article

References (65)

1. Karmali MA. Infection by Shiga toxin-producing Escherichia coli: an overview. Mol Biotechnol 2004;26:117-122
2. Tarr PI, Gordon CA, Chandler WL. Shiga toxin-producing Escherichia coli and the haemolytic uraemic syndrome. Lancet 2005;365:1073-1086
3. Caprioli A, Morabito S, Brugereb H, et al. Enterohaemorrhagic Escherichia coli: emerging issues on virulence and modes of transmission. Vet Res 2005;36:289-311
4. Scotland SM, Smith HR, Rowe B. Two distinct toxins active on Vero cells from Escherichia coli O157:H7. Lancet 1985;2:885-886
5. O'Brien AD, Tesh VL, Donohue-Rolfe A, et al. Shiga toxin: biochemistry, genetics, mode of action, and role in pathogenesis. Curr Top Microbiol Immunol 1992;180:65-94
6. Sandvig K. Shiga toxins. Toxicon 2001;39:1629-1635
7. 1c) in Escherichia coli isolated from humans. J Clin Microbiol 2002;40:1441-1446
8. Friedrich AW, Borell J, Bielaszewska M, et al. Shiga toxin 1c-producing Escherichia coli strains: phenotypic and genetic characterization and association with human disease. J Clin Microbiol 2003;41:2448-2453
9. Bürk C, Dietrich R, Acar G, et al. Identification and characterization of a new variant of Shiga toxin 1 in Escherichia coli ONT:H19 of bovine origin. J Clin Microbiol 2003;41:2106-2112
10. Kuczius T, Bielaszewska M, Friedrich AW, et al. A rapid method for the discrimination of genes encoding classical Shiga toxin (Stx) 1 and its variants, Stx1c and Stx1d, in Escherichia coli. Mol Nutr Food Res 2004;48:515-521
11. - strain E32511. Infect Immun 1991;59:1065-1073
12. Jelacic JK, Damrow T, Chen GS, et al. Shiga toxin-producing Escherichia coli in Montana: bacterial genotypes and clinical profiles. J Infect Dis 2003;188:719-729
13. Melton-Celsa AR, Darnell SC, O'Brien AD. Activation of Shiga-like toxins by mouse and human intestinal mucus correlates with virulence of enterohemorrhagic Escherichia coli O91:H21 isolates in orally infected, streptomycin-treated mice. Infect Immun 1996;64:1569-1576
14. Pierard D, Muyldermas G, Moriau L, et al. Identification of new Verocytotoxin type 2 variant B-subunit genes in human and animal Escherichia coli isolates. J Clin Microbiol 1998;36:3317-3322
15. Sonntag AK, Bielaszewska M, Mellmann A, et al. Shiga toxin 2e-producing Escherichia coli from humans and pigs differ by their virulence profiles and interaction with intestinal epithelial cells. Appl Environ Microbiol 2005;71:8855-8863
16. Schmidt H, Scheef J, Morabito S, et al. A new Shiga toxin 2 variant (Stx2f) from Escherichia coli isolated from pigeons. Appl Environ Microbiol 2000;66:1205-1208
17. Sonntag A-K, Zenner E, Karch H, et al. Pigeons as a possible reservoir of Shiga toxin 2f-producing Escherichia coli pathogenic to humans. Berl Munch Tierarztl Wochenschr 2005;118:464-470
18. Beutin L, Krause G, Zimmermann S, et al. Characterization of Shiga toxin-producing Escherichia coli strains isolated from human patients in Germany over a 3-year period. J Clin Microbiol 2004;42:1099-1108
19. Staschen B, Friedrich AW, Schröder M, et al. Incidence of enterohemorrhagic Escherichia coli (EHEC) in hospitalized children with diarrhea in northern Germany. Monatsschrift Kinderheilkunde 2004;152:1077-1083
20. Kehl KS, Havens P, Behnke CE, et al. Evaluation of the premier EHEC assay for detection of Shiga toxin-producing Escherichia coli. J Clin Microbiol 1997;35:2051-2054
21. Karmali MA, Petric M, Bielaszewska M. Evaluation of a microplate latex agglutination method (Verotox-F) for detecting and characterizing verotoxins (Shiga toxins) in Escherichia coli. J Clin Microbiol 1999;37:396-399
22. Zhang W, Bielaszewska M, Friedrich AW, et al. Transcriptional analysis of genes encoding Shiga toxin 2 and its variants in Escherichia coli. Appl Environ Microbiol 2005;71:558-561
23. Friedrich AW, Bielaszewska M, Zhang WL, et al. Escherichia coli harboring Shiga toxin 2 gene variants: frequency and association with clinical symptoms. J Infect Dis 2002;185:74-84
24. Kusumoto M, Nishiya Y, Kawamura Y, et al. Identification of an insertion sequence, IS1203 variant, in a Shiga toxin 2 gene of Escherichia coli O145:H7. J Biosci Bioeng 1999;87:93-96
25. Reischl U, Youssef MT, Kilwinski J, et al. Real-time fluorescence PCR assays for detection and characterization of Shiga toxin, intimin, and enterohemolysin genes from Shiga toxin-producing Escherichia coll. J Clin Microbiol 2002;40:2555-2565
26. Pulz M, Matussek A, Monazahian M, et al. Comparison of a Shiga toxin enzyme-linked immunosorbent assay and two types of PCR for detection of shiga toxin-producing Escherichia coli in human stool specimens. J Clin Microbiol 2003;41:4671-4675
27. Mellmann A, Bielaszewska M, Zimmerhackl LB, et al. Enterohemorrhagic Escherichia coli in human infection: in vivo evolution of a bacterial pathogen. Clin Infect Dis 2005;41:785-792
28. -. Int J Med Microbiol 2002;292:207-214
29. - and O157:H7: characterization and evolutionary considerations. Infect Immun 2003;71:3634-3638
30. - from E. coli O157:H7. Appl Environ Microbiol 2005;71:4875-4878
31. Dobrindt U, Agerer F, Michaelis K, et al. Analysis of genome plasticity in pathogenic and commensal Escherichia coli isolates by use of DNA arrays. J Bacteriol 2003;185:1831-1840
32. Oswald E, Schmidt H, Morabito S, et al. Typing of intimin genes in human and animal enterohemorrhagic and enteropathogenic Escherichia coli: characterization of a new intimin variant. Infect Immun 2000;68:64-71
33. Zhang W-L, Köhler B, Oswald E, et al. Genetic diversity of intimin genes of attaching and effacing Escherichia coli strains. J Clin Microbiol 2002;40:4486-4492
34. Nataro JP, Kaper JB. Diarrheagenic Escherichia coli. Clin Microbiol Rev 1998;11:142-201
35. Tarr PI, Bilge SS, Vary JC, et al. Iha: a novel Escherichia coli O157:H7 adherence-conferring molecule encoded on a recently acquired chromosomal island of conserved structure. Infect Immun 2000;68:1400-1407
36. Nicholls L, Grant TH, Robins-Browne RM. Identification of a novel genetic locus that is required for in vitro adhesion of a clinical isolate of enterohaemorrhagic Escherichia coli to epithelial cells. Mol Microbiol 2000;35:275-288
37. Paton AW, Srimanote P, Woodrow MC, et al. Characterization of Saa, a novel autoagglutinating adhesin produced by locus of enterocyte effacement-negative Shiga-toxigenic Escherichia coli strains that are virulent for humans. Infect Immun 2001;69:6999-7009
38. -. J Clin Microbiol 2004;42:4697-4701
39. Doughty S, Sloan J, Bennett-Wood V, et al. Identification of a novel fimbrial gene cluster related to long polar fimbriae in locus of enterocyte effacement-negative strains of enterohemorrhagic Escherichia coli. Infect Immun 2002;70:6761-6769
40. Karmali MA, Mascarenhas M, Shen S, et al. Association of genomic O island 122 of Escherichia coli EDL 933 with verocytotoxin-producing Escherichia coli seropathotypes that are linked to epidemic and/or serious disease. J Clin Microbiol 2003;41:4930-4940
41. Jores J, Wagner S, Rumer L, et al. Description of a 111-kb pathogenicity island (PAI) encoding various virulence features in the enterohemorrhagic E. coli (EHEC) strain RW1374 (O103:H2) and detection of a similar PAI in other EHEC strains of serotype O103:H2. Int J Med Microbiol 2005;294:417-425
42. Lathem WW, Grys TE, Witowski SE, et al. StcE, a metalloprotease secreted by Escherichia coli O157:H7, specifically cleaves C1 esterase inhibitor. Mol Microbiol 2002;45:277-288
43. 5 cytotoxins produced by Shiga toxigenic Escherichia coli. J Exp Med 2004;200:35-46
44. Bielaszewska M, Fell M, Greune L, et al. Characterization of cytolethal distending toxin genes and expression in Shiga toxin-producing Escherichia coli strains of non-O157 serogroups. Infect Immun 2004;72:1812-1816
45. Bielaszewska M, Sinha B, Kuczius T, et al. Cytolethal distending toxin from Shiga toxin-producing Escherichia coli O157 causes irreversible G2/M arrest, inhibition of proliferation and death of human endothelial cells. Infect Immun 2005;73:552-562
46. Bielaszewska M, Zhang W, Tarr PI, et al. Molecular profiling and phenotype analysis of Escherichia coli O26:H11 and O26:NM: secular and geographic consistency of enterohemorrhagic and enteropathogenic isolates. J Clin Microbiol 2005;43:4225-4228
47. Bielaszewska M, Tarr PI, Karch H, et al. Phenotypic and molecular analysis of tellurite resistance among enterohemorrhagic Escherichia coli O157:H7 and sorbitol-fermenting O157:NM clinical isolates. J Clin Microbiol 2005;43:452-454
48. Friedrich AW, Köck R, Bielaszewska M, et al. Distribution of the urease gene cluster among and urease activities of enterohemorrhagic Escherichia coli O157 isolates from humans. J Clin Microbiol 2005;43:546-550
49. Thelestam M, Frisan T. Cytolethal distending toxins. Rev Physiol Biochem Pharmacol 2004;152:111-133
50. Cortes-Bratti X, Frisan T, Thelestam M. The cytolethal distending toxins induce DNA damage and cell cycle arrest. Toxicon 2001;39:1729-1736
51. Scott DA, Kaper JB. Cloning and sequencing of the genes encoding Escherichia coli cytolethal distending toxin. Infect Immun 1994;62:244-251
52. Pickett CL, Cottle DL, Pesci EC, et al. Cloning, sequencing, and expression of the Escherichia coli cytolethal distending toxin genes. Infect Immun 1994;62:1046-1051
53. Peres SY, Marches O, Daigle F, et al. A new cytolethal distending toxin (CDT) from Escherichia coli producing CNF2 blocks HeLa cell division in G2/M phase. Mol Microbiol 1997;24:1095-1107
54. Elwell CA, Dreyfus LA. DNase I homologous residues in CdtB are critical for cytolethal distending toxin-mediated cell cycle arrest. Mol Microbiol 2000;37:952-963
55. Lara-Tejero M, Galan JE. A bacterial toxin that controls cell cycle progression as a deoxyribonuclease I-like protein. Science 2000;290:354-357
56. Lara-Tejero M, Galan JE. CdtA, CdtB, and CdtC form a tripartite complex that is required for cytolethal distending toxin activity. Infect Immun 2001;69:4358-4365
57. Deng K, Hansen EJA. CdtA-CdtC complex can block killing of HeLa cells by Haemophilus ducreyi cytolethal distending toxin. Infect Immun 2003;71:6633-6640
58. Toth I, Herault F, Beutin L, et al. Production of cytolethal distending toxins by pathogenic Escherichia coli isolated from human and animal sources: Establishment of the existence of a new cdt variant (type IV). J Clin Microbiol 2003;41:4285-4291
59. Prager R, Annemuller S, Tschäpe H. Diversity of virulence patterns among shiga toxin-producing Escherichia coli from human clinical cases-need for more detailed diagnostics. Int J Med Microbiol 2005;295:29-38
60. Pickett CL, Lee RB, Eyigor A, et al. Patterns of variations in Escherichia coli strains that produce cytolethal distending toxin. Infect Immun 2004;72:684-690
61. Richardson SE, Karmali MA, Becker LE, et al. The histopathology of the hemolytic uremic syndrome associated with verocytotoxin-producing Escherichia coli infections. Hum Pathol 1988;19:1102-1108
62. Matussek A, Lauber J, Bergau A, et al. Molecular and functional analysis of Shiga toxin-induced response patterns in human vascular endothelial cells. Blood 2003;102:1323-1332
63. Gerber A, Karch H, Allerberger F, et al. Clinical course and the role of Shiga toxin-producing Escherichia coli infection in the hemolytic-uremic syndrome in pediatric patients, 1997-2000, in Germany and Austria: a prospective study. J Infect Dis 2002;186:493-500
64. Sonntag A, Prager R, Bielaszewska M, et al. Phenotypic and genotypic analyses of enterohemorrhagic Escherichia coli O145 strains from patients in Germany. J Clin Microbiol 2004;42:954-962
65. Misselwitz J, Karch H, Bielazewska M, et al. Cluster of hemolytic-uremic syndrome caused by Shiga toxin-producing Escherichia coli O26:H11. Pediatr Infect Dis J 2003;22:349-354